Cosby Jury Ends First Day Of Deliberations With No Verdict, Will Resume In Morning

NORRISTOWN, Pa. (KDKA) -- The jury in Bill Cosby's aggravated indecent assault case deliberated for over four hours Monday. They will reconvene Tuesday morning at 9 a.m.

Day six of the trial brought some surprises.

Camille Cosby was all smiles escorting her husband into the courthouse for the first time during the trial and for what would be the final day of testimony.

The prosecution rested Friday after calling 12 witnesses. One of them was a woman who said Cosby drugged and sexually assaulted her in almost the exact same way Andrea Constand said Cosby drugged and sexually assaulted her.

Cosby's publicist, Andrew Wyatt, hinted the comedian may testify but we learned quickly on Monday that would not be the case.

The defense called one police officer briefly, that had already been called by the prosecution and then rested, leaving many in the courtroom surprised there was not more.

In closing arguments, Cosby's lead attorney, Brian McMonagle, attacked Constand's credibility, saying she told police the assault happened on different dates.

"She would remember the next day and every day if there was a sexual assault," he said.

He also argued Constand told detectives her contact with the comedian after the alleged assault was "rare and brief" yet there were 72 phone calls between them. McMonagle reminded the jury that in 2005 the Montgomery County District Attorney's Office, "put this case in a trash can."

District Attorney Kevin Steele repeated Cosby's alleged words to the jury, "Three friends to make you relax," referring to the three blue pills Cosby allegedly gave Constand that left her unable to move.

Steele said defense counsel's suggestions the two had a romantic sexual encounter is not only untrue but "you should be insulted by that." Steele argued a woman has a right to say no and by giving Constand those pills Cosby took away her right.

Join The Conversation On The KDKA Facebook Page
Stay Up To Date, Follow KDKA On Twitter

Read more
f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.